A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma

Aichi Cancer Center Hospital, Nagoya

National Cancer Center Hospital East, Kashiwa

Iizuka Hospital, Iizuka

Kurume University Hospital, Kurume

Sapporo-Kosei General Hospital, Sapporo

Kanazawa University Hospital, Kanazawa

Kanagawa Cancer Center, Yokohama

Yokohama City University Medical Center, Yokohama

Kindai University Hospital, Sayama

National Cancer Center Hospital, Chuo-ku

Kyorin University Hospital, Mitaka

Japanese Red Cross Musashino Hospital, Musashino

Chiba University Hospital, Chiba

Hiroshima University Hospital, Hiroshima

Okayama University Hospital, Okayama

Osaka City University Hospital, Osaka

Osaka International Cancer Institute, Osaka